<DOC>
	<DOCNO>NCT01806311</DOCNO>
	<brief_summary>Clinical trial evalate pharmacokinetic interaction safety single dose amlodipine10mg candesartan32mg combiation dose amlodipine10mg candesartan32mg healthy male volunteer .</brief_summary>
	<brief_title>Safety Pharmacokinetics Study amlodipine10mg candesartan32mg</brief_title>
	<detailed_description />
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>1 . Healthy male , Age 20 45 2 . Subject must willing able provide write informed consent study . 1 . History significant sickness , liver system , gall bladder system , kidney , nerve system , respiratory system , blood tumor , endocrine system , urinary system , mental disease , muscloskeletal system , immunity system , ear , nose throat system cardiovascular system . 2 . History significant gastrointestinal system surgery gastrointestinal . 3 . History significant hypersensitivity amlodipine , candesartan , aspirin , antibiotic . 4 . Over 10 tobaccos day . 5 . Other condition opinion investigator preclude endrollment study .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Safety</keyword>
	<keyword>Male</keyword>
</DOC>